However, since insulin resistance is one of the key pathophysiological mechanisms of T2D, insulin treatment can still contribute to this resistance, which is why it should be used at key moments in diabetes, titrating in a timely manner and addressing each situation specifically. This evidence concerns the gene INS and diabetes mellitus.